Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

NCT06292117 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT06292117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
Lead sponsor
University of Virginia
Phase
Observational
Overall status
Recruiting
Start date
April 16, 2024
Completion date
October 31, 2026
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cyp2c19 polymorphism, ischemic stroke